These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 3612134)

  • 1. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
    Nissbrandt H; Carlsson A
    J Neurochem; 1987 Sep; 49(3):959-67. PubMed ID: 3612134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A; Nissbrandt H
    Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats.
    Venero JL; Machado A; Cano J
    J Neurochem; 1991 Jun; 56(6):1940-8. PubMed ID: 1709201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reserpine-insensitive dopamine release in the substantia nigra?
    Elverfors A; Nissbrandt H
    Brain Res; 1991 Aug; 557(1-2):5-12. PubMed ID: 1720998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Jun; 37(2):249-55. PubMed ID: 954808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra.
    Nissbrandt H; Pileblad E; Carlsson A
    J Pharm Pharmacol; 1985 Dec; 37(12):884-9. PubMed ID: 2868096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
    Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
    J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
    Waldmeier PC; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
    Hallman H; Jonsson G
    Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine synthesis in inbred mouse strains which differ in numbers of dopamine neurons.
    Sved AF; Baker HA; Reis DJ
    Brain Res; 1984 Jun; 303(2):261-6. PubMed ID: 6744023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O; Mohringe B; Fowler CJ
    J Neural Transm; 1987; 69(3-4):163-77. PubMed ID: 2957465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age effects on monoamine turnover of the rat substantia nigra.
    Venero JL; Machado A; Cano J
    Brain Res; 1991 Aug; 557(1-2):109-14. PubMed ID: 1747745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors.
    Nissbrandt H; Engberg G; Wikström H; Magnusson T; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):148-61. PubMed ID: 3141816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
    Treseder SA; Rose S; Jenner P
    Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.
    Lappalainen J; Hietala J; Koulu M; Sjöholm B; Syvälahti E
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):861-72. PubMed ID: 1722342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a short period of vitamin E-deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat.
    Castaño A; Herrera AJ; Cano J; Machado A
    Neuroscience; 1993 Mar; 53(1):179-85. PubMed ID: 7682297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model.
    Karoum F; Chrapusta SJ; Egan MF
    J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of dopamine release in the denervated striatum.
    Altar CA; Marien MR
    Neurosci Lett; 1989 Jan; 96(3):329-34. PubMed ID: 2497410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.